NR3C1 and epilepsy: We then examined whether pathophysiologically relevant concentrations of cortisol could suppress both innate and T cell mediated cytokine induction, and the potential for antagonising suppression using the glucocorticoid receptor (GR) antagonist, RU-486, which has been shown to cross the blood brain barrier in studies into epilepsy and brain cancer [8, 53].